Jeon Min-Tae, Kim Sang Ryong
School of Life Sciences, Kyungpook National University, Daegu 700-842, Republic of Korea ; BK21 plus KNU Creative BioResearch Group, Kyungpook National University, Daegu 700-842, Republic of Korea.
School of Life Sciences, Kyungpook National University, Daegu 700-842, Republic of Korea ; BK21 plus KNU Creative BioResearch Group, Kyungpook National University, Daegu 700-842, Republic of Korea ; Institute of Life Science and Biotechnology, Kyungpook National University, Daegu 702-701, Republic of Korea ; Brain Science and Engineering Institute, Kyungpook National University, Daegu 700-842, Republic of Korea.
Biomed Rep. 2015 Mar;3(2):137-140. doi: 10.3892/br.2014.397. Epub 2014 Dec 9.
Although there are ongoing intensive research efforts, no effective pharmacological therapies for Parkinson's disease (PD) have been developed thus far. However, with the development of efficient gene delivery systems, gene therapy for PD has become a focus of research and increasing evidence suggests that continuous production of neurotrophic factors play a significant role in the functional restoration of the nigrostriatal dopaminergic (DA) system. Our recent study reported that the transduction of DA neurons with ras homolog enriched in brain, which has an S16H mutation [Rheb(S16H)], protected the nigrostriatal DA projection in a neurotoxin model of PD . In addition, Rheb(S16H) expression significantly increased the levels of glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor, which contributed to the neuroprotective effects of Rheb(S16H) in DA neurons in the adult brain, indicating that the activation of the signaling pathways involved in cell survival by a specific gene delivery, such as Rheb(S16H) to adult neurons, may be a useful strategy to protect neural systems in the adult brain. In the present study, a brief overview of our recent studies is provided, which demonstrates the neuroprotective mechanisms of Rheb(S16H) on the nigrostriatal DA projection in the adult brain.
尽管目前正在进行深入的研究,但迄今为止尚未开发出针对帕金森病(PD)的有效药物治疗方法。然而,随着高效基因递送系统的发展,PD的基因治疗已成为研究热点,越来越多的证据表明神经营养因子的持续产生在黑质纹状体多巴胺能(DA)系统的功能恢复中起重要作用。我们最近的研究报告称,用富含脑的ras同源物(具有S16H突变[Rheb(S16H)])转导DA神经元,在PD神经毒素模型中保护了黑质纹状体DA投射。此外,Rheb(S16H)的表达显著增加了胶质细胞系源性神经营养因子和脑源性神经营养因子的水平,这有助于Rheb(S16H)对成年大脑DA神经元的神经保护作用,表明通过特定基因递送(如将Rheb(S16H)递送至成年神经元)激活细胞存活相关信号通路可能是保护成年大脑神经系统的有用策略。在本研究中,对我们最近的研究进行了简要概述,展示了Rheb(S16H)对成年大脑黑质纹状体DA投射的神经保护机制。